Bernard Fisher receives AACR Lifetime Achievement Award

PHILADELPHIA Bernard Fisher, M.D., the renowned clinical cancer researcher whose career has been dedicated toward improving survival as well as quality of life for women with breast cancer, will receive the American Association for Cancer Research Award for Lifetime Achievement in Cancer Research.

The award will be presented April 2 during ceremonies at AACR's 97th Annual Meeting in Washington, D.C.

Dr. Fisher 's early work on tumor metastasis paved the way for later hypotheses about the spread of this disease. He used clinical trials to confirm that patterns of tumor spread are not solely dictated by anatomical considerations, but are also influenced by intrinsic factors in the tumor cells and the organs they invade.

Dr. Fisher's systematic clinical trials changed the way physicians manage patients with breast cancer. Together with a consortium of colleagues, he evaluated the effect of radical surgical procedures for breast cancer and found that radical mastectomy was no more effective than total mastectomy. Further investigations revealed that a combination of lumpectomy and radiation therapy was equally effective as total mastectomy.

Dr. Fisher and his colleagues also were instrumental in defining the effectiveness of adjuvant chemotherapy and hormonal therapy with the synthetic estrogen tamoxifen in treating breast cancer as a systemic disease. His studies revealed that tamoxifen substantially reduces the incidence of breast cancer in high-risk women when taken as a preventative measure.

"Dr. Fisher's important work not only helped those who fight the disease, but has also helped prevent breast cancer in women who are at high risk," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "We are honored to recognize Dr. Fisher's exemplary contributions to the field of breast cancer research and improvement in the quality of life for women who struggle with this disease."

Dr. Fisher is a 194

Contact: Russell Vanderboom, Ph.D.
American Association for Cancer Research

Page: 1 2

Related biology news :

1. Fisheries group calls for science-based approach to address climate impacts
2. The Biology and Fisheries of the Slipper Lobster
3. The Biology and Fisheries of the Slipper Lobster
4. Fisheries linked to decline in galapagos waved albatross population
5. Fisheries science student describes new species of mussel
6. Carnegie Mellons Peter Adams receives EPA research grant
7. Philadelphia ecologist receives top Mongolia honor
8. VIB scientist receives major research grant
9. Maynard Olson receives $500,000 Gruber Genetics Prize
10. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
11. Wright State scientist receives grant to help clean up polluted American harbors

Post Your Comments:

(Date:11/14/2019)... (PRWEB) , ... November 13, 2019 , ... Personalized ... the first patients in an FDA approved clinical trial for stem cell treatment ... the formation of the company as a subsidiary of VetStem Biopharma. , In July ...
(Date:11/12/2019)... ... 12, 2019 , ... The Arnold and Mabel Beckman Foundation ... institutions for its Instrumentation Grant for Advanced Light-Sheet Microscopy and Data Science ... for the acquisition of instrumentation, development and maintenance; support for data science collaborations ...
(Date:11/9/2019)... ... November 08, 2019 , ... StageBio ... histology, pathology, biomarker development, and archiving services for the biopharmaceutical, medical device ... Histo-Scientific Research Laboratories (HSRL), Vet Path Services (VPS) and Tox Path Specialists ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... , ... November 04, 2019 ... ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene ... cell line development technology, GPEx® Boost. The technology enhances Catalent’s proven GPEx ...
(Date:11/2/2019)... , ... October 31, 2019 , ... ... Adaptive Biotechnologies in a live webinar on Friday, November 15, ... immuno-oncology. , Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell ...
(Date:10/29/2019)... ... 28, 2019 , ... CaroGen Corporation , a biotechnology company, today announced ... Professor Jack R Wands, MD, of Brown University , Dr. Steve Projan, ... Mor, MD, PhD, of Wayne State University, formerly a professor at Yale University School ...
(Date:10/22/2019)... ... ... nQ Medical, Inc. of Cambridge, MA, was recognized in the top 5 ... at a showcase event yesterday in Los Angeles. nQ competed against 3,500 early-stage U.S. ... near-term growth projections to be named one of the most fundable companies in America. ...
Breaking Biology Technology:
Cached News: